average monthly weight loss on tirzepatide Adults with obesity using maintain 'remarkable' at 88 weeks Switching Semaglutide to Tirzepatide |

As the global obesity crisis continues, GLP-1 receptor agonists have rapidly emerged as one of the most important therapeutic breakthroughs in metabolic medicine

If compounded GLP-1 drugs become unavailable, employers will face increased pressure to provide coverage for GLP-1 medications for their members who are obese overweight with a metabolic complication

Wunderlich J, Kotov V, Votborg-Novel L, Ntalla C, Geffken M, Peine S, Portugal S, Strauss J

Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics

This encourages the body to use the stored fat for energy instead of relying on sugar consumption

The Federal Government Leads 200 Diet Related Efforts Aimed to Help, But It Lacks Strategy